SK5982003A3 - 1-Methylcarbapenem derivatives - Google Patents

1-Methylcarbapenem derivatives Download PDF

Info

Publication number
SK5982003A3
SK5982003A3 SK598-2003A SK5982003A SK5982003A3 SK 5982003 A3 SK5982003 A3 SK 5982003A3 SK 5982003 A SK5982003 A SK 5982003A SK 5982003 A3 SK5982003 A3 SK 5982003A3
Authority
SK
Slovakia
Prior art keywords
group
azetidin
thio
hydroxyethyl
carboxylic acid
Prior art date
Application number
SK598-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Yoshiyuki Kobayashi
Tsuyoshi Shinozuka
Osamu Kanno
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of SK5982003A3 publication Critical patent/SK5982003A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK598-2003A 2000-11-16 2001-11-14 1-Methylcarbapenem derivatives SK5982003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000350063 2000-11-16
PCT/JP2001/009960 WO2002040483A1 (fr) 2000-11-16 2001-11-14 Dérivés 1-méthylcarbapenem

Publications (1)

Publication Number Publication Date
SK5982003A3 true SK5982003A3 (en) 2004-05-04

Family

ID=18823361

Family Applications (1)

Application Number Title Priority Date Filing Date
SK598-2003A SK5982003A3 (en) 2000-11-16 2001-11-14 1-Methylcarbapenem derivatives

Country Status (24)

Country Link
US (1) US7001897B2 (fr)
EP (1) EP1340757B1 (fr)
KR (1) KR100832287B1 (fr)
CN (1) CN1289498C (fr)
AT (1) ATE342266T1 (fr)
AU (2) AU2002215212B2 (fr)
BR (1) BR0115454A (fr)
CA (1) CA2429346A1 (fr)
CZ (1) CZ300137B6 (fr)
DE (1) DE60123827T2 (fr)
DK (1) DK1340757T3 (fr)
ES (1) ES2273902T3 (fr)
HU (1) HUP0303204A3 (fr)
IL (1) IL155931A0 (fr)
MX (1) MXPA03004372A (fr)
NO (1) NO20032198L (fr)
NZ (1) NZ525934A (fr)
PL (1) PL362132A1 (fr)
PT (1) PT1340757E (fr)
RU (1) RU2247725C2 (fr)
SK (1) SK5982003A3 (fr)
TW (1) TWI242013B (fr)
WO (1) WO2002040483A1 (fr)
ZA (1) ZA200303796B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI295989B (fr) 2001-07-18 2008-04-21 Mitsui Chemicals Inc
KR100451670B1 (ko) * 2001-09-14 2004-10-08 한국화학연구원 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법
KR100599876B1 (ko) * 2004-08-31 2006-07-13 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
EP1637529A1 (fr) * 2004-09-20 2006-03-22 4Sc Ag Nouveaux analogues de piperidin-4-yl-thiazole-carboxamide en tant qu'inhibiteurs de proliferation de lymphocytes T er leurs utilisations
US7601745B2 (en) * 2004-09-27 2009-10-13 4Sc Ag Heterocyclic NF-kB inhibitors
JP5182088B2 (ja) 2006-04-19 2013-04-10 アステラス製薬株式会社 アゾールカルボキサミド誘導体
CN101328179B (zh) * 2007-06-15 2011-01-12 山东轩竹医药科技有限公司 含有氧代氮杂环的巯基吡咯烷培南衍生物
EP2206707B1 (fr) 2007-10-24 2014-07-23 Astellas Pharma Inc. Composé à base d'azolecarboxamide ou son sel
RU2445314C9 (ru) 2008-01-18 2013-04-10 Мерк Шарп Энд Домэ Корп. Ингибиторы бета-лактамаз
CA2895448A1 (fr) 2012-12-19 2014-06-26 Novartis Ag Inhibiteurs d'autotaxine
US9409895B2 (en) 2012-12-19 2016-08-09 Novartis Ag Autotaxin inhibitors
WO2022268935A2 (fr) * 2021-06-23 2022-12-29 F. Hoffmann-La Roche Ag Nouveau procédé

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053508T3 (es) * 1986-11-24 1994-08-01 Fujisawa Pharmaceutical Co Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
GB9210096D0 (en) * 1992-05-11 1992-06-24 Fujisawa Pharmaceutical Co 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives and their preparation
AU682510B2 (en) * 1993-07-01 1997-10-09 Pfizer Japan Inc. 2-(1-(1,3-thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives
DE4423612A1 (de) * 1994-07-06 1996-01-11 Basf Ag 2-[(Dihydro)pyrazolyl-3'-oxymethylen]-anilide, Verfahren zu ihrer Herstelung und ihre Verwendung
TW445265B (en) * 1996-11-25 2001-07-11 Meiji Seika Kaisha Carbapenem derivatives and antimicrobial agents
TW200403244A (en) * 2002-05-14 2004-03-01 Sankyo Co 1β-Methylcarbapenem derivatives for oral use
JP2004043438A (ja) * 2002-05-15 2004-02-12 Sankyo Co Ltd 1−メチルカルバペネム誘導体を含有する医薬

Also Published As

Publication number Publication date
AU1521202A (en) 2002-05-27
NZ525934A (en) 2004-09-24
ATE342266T1 (de) 2006-11-15
IL155931A0 (en) 2003-12-23
CN1486317A (zh) 2004-03-31
TWI242013B (en) 2005-10-21
NO20032198L (no) 2003-07-16
MXPA03004372A (es) 2003-08-19
CZ300137B6 (cs) 2009-02-18
HUP0303204A2 (hu) 2003-12-29
EP1340757A1 (fr) 2003-09-03
ES2273902T3 (es) 2007-05-16
NO20032198D0 (no) 2003-05-15
CN1289498C (zh) 2006-12-13
HUP0303204A3 (en) 2010-04-28
KR20030048151A (ko) 2003-06-18
DK1340757T3 (da) 2007-02-12
EP1340757A4 (fr) 2005-01-26
CA2429346A1 (fr) 2002-05-23
KR100832287B1 (ko) 2008-05-26
BR0115454A (pt) 2003-09-23
WO2002040483A1 (fr) 2002-05-23
US7001897B2 (en) 2006-02-21
PT1340757E (pt) 2006-12-29
RU2247725C2 (ru) 2005-03-10
AU2002215212B2 (en) 2004-10-14
DE60123827T2 (de) 2007-05-31
ZA200303796B (en) 2004-08-16
US20040014962A1 (en) 2004-01-22
CZ20031325A3 (cs) 2003-10-15
DE60123827D1 (en) 2006-11-23
PL362132A1 (en) 2004-10-18
EP1340757B1 (fr) 2006-10-11

Similar Documents

Publication Publication Date Title
HU196800B (en) Process for producing carbepeneme derivatives and pharmaceutical compositions containing them as active component
JPH0853453A (ja) 2−[1−(1,3−チアゾリン−2−イル)アゼチジン−3−イル]チオ−カルバペネム化合物
SK5982003A3 (en) 1-Methylcarbapenem derivatives
JPH05339269A (ja) 1−メチルカルバペネム誘導体
RU2097383C1 (ru) Производные карбапенема и способ их получения
CZ298246B6 (cs) Deriváty 1-methylkarbapenu, zpusob jejich prípravy a farmaceutické prostredky, které je obsahují
EP3430013B1 (fr) Composes de carbapenem
HU191066B (en) Process for preparing carbapenem derivatives
RU2162088C2 (ru) 1-метилкарбапенем или его фармакологически приемлемые соли, композиция, способ предупреждения или лечения бактериальных инфекций
JP3199300B2 (ja) 1−メチルカルバペネム誘導体
JP2002212182A (ja) 1−メチルカルバペネム誘導体
JP2004043438A (ja) 1−メチルカルバペネム誘導体を含有する医薬
JPH1171277A (ja) 1−メチルカルバペネム誘導体を含有する抗菌剤
WO2004067532A1 (fr) Nouveaux dérivés de carbapenem
HU213265B (en) Process for producing 4-(substituted alkyl)-carbapenem derivatives and pharmaceutical compositions containing the same
JPH10204086A (ja) 1−メチルカルバペネム誘導体
JP2007291048A (ja) 1β−メチルカルバペネム誘導体を含有する医薬
JPH09249668A (ja) カルバペネム化合物、その製造法および剤
WO2006049148A1 (fr) DÉRIVÉ DE 1β-MÉTHYLCARBAPÉNÈME
JP2006151815A (ja) 新規カルバペネム誘導体
JPH04321688A (ja) 2−(置換ピロリジニルチオ)カルバペネム誘導体
JPH1081686A (ja) カルバペネム化合物、その製造法および剤
JP2006151970A (ja) 1β−メチルカルバペネム誘導体
WO1994005667A1 (fr) Derives de carbapenem et procedes pour leur preparation
JPH04234886A (ja) 1−アザビシクロ[3.2.0]ヘプト−2−エン−2−カルボン酸化合物

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure